Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2a Study of Ropinirole for Amyotrophic Lateral Sclerosis
jRCT2091220397Phase 1Completed
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing Ropinirole extended-release with Placebo (2 arms). Primary endpoint: Safety and tolerability. Started Nov 2018; status: completed.
02
Drugs
ropinirole prolonged release
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on jRCT2091220397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220397.